Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated

Melanie Ziegler1, Karen Alt1,2, Brett M Paterson3

  • 1Atherothrombosis and Vascular Biology, Baker IDI Heart &Diabetes Institute, Melbourne, Australia.

Scientific Reports
|December 3, 2016
PubMed

Insights

New molecular PET imaging detects minimal cardiac ischemia by visualizing activated platelets. This sensitive, non-invasive method aids in diagnosing coronary artery disease and stratifying patient risk.

Area of Science:

  • Cardiovascular imaging
  • Molecular imaging
  • Platelet biology

Background:

  • Diagnosis of minimal cardiac ischemia is crucial for coronary artery disease management.
  • Current methods like ECG, biomarkers, and stress testing lack sensitivity for early or minimal ischemia.
  • Activated platelets accumulate early in ischemic myocardium, presenting a potential diagnostic target.

Purpose of the Study:

  • To develop and validate a non-invasive molecular PET imaging method for detecting minimal cardiac ischemia.
  • To assess the sensitivity of PET imaging of activated platelets in identifying early myocardial ischemia.

Main Methods:

  • Induction of varying degrees of minimal myocardial ischemia in mice by ligating the left anterior descending artery.
  • Administration of a novel radiotracer (scFvanti-GPIIb/IIIa-64CuMeCOSar) targeting activated platelets.
  • Assessment using Positron Emission Tomography/Computed Tomography (PET/CT) imaging, compared with Evans Blue/TTC staining and serological biomarkers (Troponin I, H-FABP).

Main Results:

  • PET imaging successfully detected minimal degrees of myocardial ischemia.
  • Classical diagnostic methods (Evans Blue/TTC staining, Troponin I, H-FABP) were negative, indicating the sensitivity of the PET approach.
  • The novel radiotracer specifically bound to activated platelets in ischemic regions.

Conclusions:

  • Molecular PET imaging of activated platelets is a highly sensitive and unique method for detecting minimal cardiac ischemia.
  • This technique holds promise for improving the diagnosis of coronary artery disease and risk stratification in patients with ambiguous symptoms.
  • Non-invasive imaging of platelet activation offers a significant advancement in cardiovascular diagnostics.